Reviewing the outlook form 1H FY 23 and not aware of any updates the expectation is as follows for 2H FY23:
Underlying EBITDA $26.3M (full year $58M)
Underlying NPAT $13.4M (full year $30M)
I expect Final Dividend of 37.5c ps 100% franked - by my calcs we only have about $2.8M if franking credits and this will use them up, so no more franked dividends for the for the foreseeable future. Perhaps they might start doing partial franking.
Total of 57.5c fully franked dividends for FY23, yield of 6.1% fully franked
AND,
On market buy-back of another $3M over the next 6 months. (~ about 1.8% of shares)
- Forums
- ASX - By Stock
- Ann: Capral Full Year 2023 results and investor webinar
CAA
capral limited
Add to My Watchlist
0.38%
!
$10.54

Reviewing the outlook form 1H FY 23 and not aware of any updates...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$10.54 |
Change
-0.040(0.38%) |
Mkt cap ! $175.2M |
Open | High | Low | Value | Volume |
$10.58 | $10.58 | $10.41 | $66.15K | 6.317K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $10.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.60 | 379 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 10.400 |
1 | 2655 | 10.300 |
1 | 1991 | 10.200 |
1 | 250 | 10.130 |
1 | 102 | 9.800 |
Price($) | Vol. | No. |
---|---|---|
10.600 | 379 | 1 |
10.660 | 4406 | 1 |
10.690 | 2212 | 1 |
10.780 | 1081 | 1 |
10.800 | 300 | 1 |
Last trade - 15.44pm 27/06/2025 (20 minute delay) ? |
Featured News
CAA (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online